Member access

4-Traders Homepage  >  Shares  >  Euronext Paris  >  NEURONES    NRO   FR0004050250

NEURONES

 (NRO)

90
Delayed Quote. Delayed Euronext Paris - 05/17 11:21:49 am
9.2 EUR   -0.86%
3d ago NEURONES: 1st quarter 2013 revenues
05/10NEURONES SA: quaterly sales release
02/27 NEURONES: 27/02/2013 - 8.9% operating profit and €17.2 million net profit ..
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisionsForum 
Income Statement Evolution
NEURONES : Income Statement Evolution
Annual Income Statement Data
Actuals in M € Estimates in M €
Fiscal Period December 201020112012201320142015
Sales240283315334355378
Operating income (EBITDA)27,629,4-32,134,035,0
Operating profit (EBIT)24,526,328,129,631,232,0
Pre-Tax Profit (EBT)-28,7-30,831,4-
Net income-14,814,915,916,9-
EPS ( €)0,560,620,630,600,70-
Dividend per Share ( €)-0,06-0,080,080,05
Yield-0,65%-0,91%0,91%0,54%
Announcement Date03/03/2011
07:15am
03/07/2012
05:32pm
02/27/2013
04:43pm
---
Finances - Leverage
NEURONES : Finances - Leverage
Actuals in M € Estimates in M €
Fiscal Period December 201020112012201320142015
Debt------
Finance68,375,187,8101114130
Operating income (EBITDA)27,629,4-32,134,035,0
Leverage
(Debt/EBITDA)
------
Capital Expenditure-4,89----
Book Value Per Share (BVPS)-5,48 €-6,60 €7,21 €7,75 €
Cash Flow per Share-0,35 €-0,92 €0,90 €0,93 €
Announcement Date03/03/2011
07:15am
03/07/2012
05:32pm
02/27/2013
04:43pm
---
Balance Sheet Analysis
NEURONES : Balance Sheet Analysis
Assessed data source :
© 2013 Thomson Reuters
Advertisement
Financial Ratios

Size 2013e 2014e
Capitalization 219 M€ -
Company Value 118 M€ 104 M€
Valuation 2013e 2014e
PER (Price / EPS) 15,3x 13,1x
Capitalization / Revenue 0,65x 0,62x
EV / Revenue 0,35x 0,29x
EV / EBITDA 3,67x 3,06x
Yield (DPS / Price) 0,91% 0,91%
Profitability 2013e 2014e
Operating Margin (EBIT / Sales) 8,87% 8,78%
operating laverage (Delta EBIT / Delta Sales) 0,92x 0,83x
Net Margin (Net Profit / Revenue) 4,76% 4,76%
ROA (Net Profit / Asset) - -
ROE (Net Profit / Equities) 10,3% 9,60%
Rate of Dividend 13,9% 11,9%
Balance Sheet Analysis 2013e 2014e
CAPEX / Sales   - -
Cash Flow / Sales (Taux d'autofinancement) 6,48% 5,96%
Capital Intensity (Assets / Sales) - -
Financial Leverage (Net Debt / EBITDA) -3,13x -3,36x
EPS & Dividend
NEURONES : EPS Dividend
Dynamic quotes  
ON
| OFF
Copyright © 2013 Surperformance. All rights reserved.